P-05| Volume 51, SUPPLEMENT 3, e261, October 2019

Download started.


How does Trieste treat HCV in PWID? An effective coordination between addiction treatment service (SerD), the infective disease department and the liver clinic

      According to Italian data, people who inject drugs (PWID) have high prevalence of Hepatitis C Virus (HCV) infection (30-60%). PWID have inadequate access to directly acting antivirals (DAA) due to (1) their mistrust towards the healthcare system and (2) the lack of coordination between medical specialists who play a pivotal role in the diagnosis and treatment of HCV infection. We aim to describe the HCV -treatment cascade of care in Trieste on PWID.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect